OCULAR THERAPEUTIX, INC (OCUL) Class Action Lawsuit (July 2017)

Closed

19-1557 • July 7, 2017

Class Period Start

March 10, 2016

Class Period End

July 11, 2017

PSLRA Deadline

September 5, 2017

Case Allegations

10b5

Statutes of Repose

Mar 10, 2019

Country

United States

Court

Federal Court

Docket History

Apr 30, 2019

Motion to Dismiss Granted (opens in a new tab)

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Jul 6, 2018

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

May 7, 2018

Second Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in OCULAR THERAPEUTIX, INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Mar 9, 2018

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jul 7, 2017

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in OCULAR THERAPEUTIX, INC.